BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 15275951)

  • 1. Investigation of an inducible nitric oxide synthase gene (NOS2A) polymorphism in a multiple sclerosis population.
    Tajouri L; Martin V; Ovcaric M; Curtain RP; Lea RA; Csurhes P; Pender MP; Griffiths LR
    Brain Res Bull; 2004 Jul; 64(1):9-13. PubMed ID: 15275951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of a neuronal nitric oxide synthase gene (NOS1) polymorphism in a multiple sclerosis population.
    Tajouri L; Ferreira L; Ovcaric M; Curtain R; Lea R; Csurhes P; Pender MP; Griffiths LR
    J Neurol Sci; 2004 Mar; 218(1-2):25-8. PubMed ID: 14759629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No association of inducible nitric oxide synthase gene ( NOS2A) to multiple sclerosis.
    Blanco Y; Yagüe J; Graus F; Saiz A
    J Neurol; 2003 May; 250(5):598-600. PubMed ID: 12736741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No evidence for involvement of the human inducible nitric oxide synthase (iNOS) gene in susceptibility to typical migraine.
    Lea RA; Curtain RP; Shepherd AG; Brimage PJ; Griffiths LR
    Am J Med Genet; 2001 Jan; 105(1):110-3. PubMed ID: 11424980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An investigation of NOS2A promoter polymorphisms in Australian multiple sclerosis patients.
    Bugeja MJ; Booth DR; Bennetts BH; Heard RN; Burgner D; Stewart GJ
    Eur J Hum Genet; 2005 Jul; 13(7):815-22. PubMed ID: 15856071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inducible but not endothelial nitric oxide synthase polymorphism is associated with susceptibility to rheumatoid arthritis in northwest Spain.
    Gonzalez-Gay MA; Llorca J; Sanchez E; Lopez-Nevot MA; Amoli MM; Garcia-Porrua C; Ollier WE; Martin J
    Rheumatology (Oxford); 2004 Sep; 43(9):1182-5. PubMed ID: 15226517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of a functional inducible nitric oxide synthase promoter variant with susceptibility to biopsy-proven giant cell arteritis.
    Gonzalez-Gay MA; Oliver J; Sanchez E; Garcia-Porrua C; Paco L; Lopez-Nevot MA; Ollier WE; Martin J
    J Rheumatol; 2005 Nov; 32(11):2178-82. PubMed ID: 16265698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inducible nitric oxide synthase gene promoter polymorphism is associated with increased gastric mRNA expression of inducible nitric oxide synthase and increased risk of gastric carcinoma.
    Kaise M; Miwa J; Suzuki N; Mishiro S; Ohta Y; Yamasaki T; Tajiri H
    Eur J Gastroenterol Hepatol; 2007 Feb; 19(2):139-45. PubMed ID: 17272999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of a functional inducible nitric oxide synthase promoter variant with complications in type 2 diabetes.
    Morris BJ; Markus A; Glenn CL; Adams DJ; Colagiuri S; Wang L
    J Mol Med (Berl); 2002 Feb; 80(2):96-104. PubMed ID: 11907646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TNF-alpha promoter polymorphisms in multiple sclerosis: no association with -308 and -238 alleles, but the -857 alleles in associated with the disease in Turkish patients.
    Akcali A; Pehlivan S; Pehlivan M; Sever T; Akgul P; Neyal M
    Int J Immunogenet; 2010 Apr; 37(2):91-5. PubMed ID: 20082645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association analysis of nitric oxide synthases: NOS1, NOS2A and NOS3 genes, with multiple sclerosis.
    AlFadhli S; Mohammed EM; Al Shubaili A
    Ann Hum Biol; 2013 Jul; 40(4):368-75. PubMed ID: 23826716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between achalasia and nitric oxide synthase gene polymorphisms.
    Mearin F; García-González MA; Strunk M; Zárate N; Malagelada JR; Lanas A
    Am J Gastroenterol; 2006 Sep; 101(9):1979-84. PubMed ID: 16848803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P-selectin glycoprotein ligand-1 variable number of tandem repeats (VNTR) polymorphism in patients with multiple sclerosis.
    Scalabrini D; Galimberti D; Fenoglio C; Comi C; De Riz M; Venturelli E; Castelli L; Piccio L; Ronzoni M; Lovati C; Mariani C; Monaco F; Bresolin N; Scarpini E
    Neurosci Lett; 2005 Nov; 388(3):149-52. PubMed ID: 16039046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of a genetic variation of a variable number tandem repeat polymorphism of interleukin-6 gene in patients with multiple sclerosis.
    Schmidt S; Papassotiropoulos A; Sotgiu S; Kölsch H; Arru G; Fois ML; Haase CG; Schmitz S; König N; Harzheim M; Heun R; Klockgether T
    J Neurol; 2003 May; 250(5):607-11. PubMed ID: 12736743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An inducible nitric oxide synthase polymorphism is associated with the risk of recurrent depressive disorder.
    Gałecki P; Maes M; Florkowski A; Lewiński A; Gałecka E; Bieńkiewicz M; Szemraj J
    Neurosci Lett; 2010 Dec; 486(3):184-7. PubMed ID: 20869428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inducible nitric oxide synthase polymorphism is associated with susceptibility to Henoch-Schönlein purpura in northwestern Spain.
    Martin J; Paco L; Ruiz MP; Lopez-Nevot MA; Garcia-Porrua C; Amoli MM; Calviño MC; Ollier WE; Gonzalez-Gay MA
    J Rheumatol; 2005 Jun; 32(6):1081-5. PubMed ID: 15940772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variation in the vitamin D receptor gene is associated with multiple sclerosis in an Australian population.
    Tajouri L; Ovcaric M; Curtain R; Johnson MP; Griffiths LR; Csurhes P; Pender MP; Lea RA
    J Neurogenet; 2005; 19(1):25-38. PubMed ID: 16076630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inducible and endothelial nitric oxide synthase genes polymorphism in inflammatory bowel disease.
    Oliver J; Gómez-Garcia M; Vilchez JR; López-Nevot MA; Piñero A; Correro F; Nieto A; Martín J
    Tissue Antigens; 2006 Apr; 67(4):326-30. PubMed ID: 16634870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic investigation of methylenetetrahydrofolate reductase (MTHFR) and catechol-O-methyl transferase (COMT) in multiple sclerosis.
    Tajouri L; Martin V; Gasparini C; Ovcaric M; Curtain R; Lea RA; Haupt LM; Csurhes P; Pender MP; Griffiths LR
    Brain Res Bull; 2006 Apr; 69(3):327-31. PubMed ID: 16564429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Polymorphism of NOS2A promoter -969(G>C) is associated with portal hypertension of liver cirrhosis].
    Cheng YQ; Wang WQ; Lin JS; Xiong P; Jiang XD
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Dec; 21(6):591-5. PubMed ID: 15583989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.